Sacubitril is an ethyl ester prodrug of LBQ657, the active neprilysin (NEP) inhibitor, and a component of LCZ696 (sacubitril/valsartan). We report herein the three-dimensional structure of LBQ657 in complex with human NEP at 2 Å resolution. The crystal structure unravels the binding mode of the compound occupying the S1, S1' and S2' sub-pockets of the active site, consistent with a competitive inhibition mode. An induced fit conformational change upon binding of the P1'-biphenyl moiety of the inhibitor suggests an explanation for its selectivity against structurally homologous zinc metallopeptidases.
CITATION STYLE
Schiering, N., D’Arcy, A., Villard, F., Ramage, P., Logel, C., Cumin, F., … Mogi, M. (2016). Structure of neprilysin in complex with the active metabolite of sacubitril. Scientific Reports, 6. https://doi.org/10.1038/srep27909
Mendeley helps you to discover research relevant for your work.